Joined-Up Approach Must Underpin European Biosimilar Procurement
Greater Harmonization Of Procurement Criteria Across Member States Is Called For
A more joined-up approach is needed on European procurement if the biosimilars market is to remain sustainable in the face of pricing and cost pressures, according to a discussion by industry stakeholders at Medicines for Europe’s 18th Biosimilar Medicines Conference.
